Chronic
Endometritis
in
Repeated miscarriage
and
Repeated implantation
failure
Prof. Aboubakr
Elnashar
Benha university, Egypt4/20/2017ABOUBAKR ELNASHAR
CONTENTS
1.Definitions
2.Clinical significance
3.Prevalence
4.Causes
5.Clinical picture
6.Diagnosis
7.Treatment
Conclusion
4/20/2017ABOUBAKR ELNASHAR
1. DEFINITION
CE:
Chronic inflammation of the endometrial lining
(Romero et al, 2004).
Persistent inflammation of the endometrium that is
characterized by the presence of plasma cells
(Johnston-MacAnanny, 2010).
4/20/2017ABOUBAKR ELNASHAR
RM:
3 or more consecutive failed pregnancies
(RCOG, 2011)
2 or more
(ASRM, 2008)
 Causes:
uterine abnormalities
Antiphospholipid antibody syndrome
endocrine disorders.
parental chromosomal imbalances/translocations
50% unexplained
(Stephenson,1996).
4/20/2017ABOUBAKR ELNASHAR
RIF
Failure to conceive following
2 or 3 ET cycles, or
Cumulative transfer of 10 good quality embryos
(El-Toukhy and Taranissi, 2006).
Causes:
Embryonic
Maternal:
uterine anatomic abnormalities
thrombophilia,
non-receptive endometrium
immunological
(Salim et al., 2002).
Idiopathic
4/20/2017ABOUBAKR ELNASHAR
Recently, there has been increasing interest in the role
of CE in RM and RIF
Limited publications
The impact of CE on reproductive capacity:
controversial
4/20/2017ABOUBAKR ELNASHAR
2. CLINICAL IMPLICATION
1. Infertility:
 CE:
RM: 42.9% to 56%.
RIF: 30.3% to 66%
Infertile women: 2.8-9%
(Kasius et al, 2011, Viana et al, 2015) suggesting:
Correlation between CE and RM or RIF rather
than infertility
{create a suboptimal IU environment
hamper endometrial receptivity}
±cause infertility
{endometrium is characterized by an abnormal
pattern of lymphocyte: an aberrant endometrial
microenvironment }
(Matteo et al., 2009). 4/20/2017ABOUBAKR ELNASHAR
2. In RM:
CE is a frequent finding (42.9% to 56%).
Antibiotic tt: significantly higher rate of
successful pregnancies compared with women
who were not treated or
with persistent disease
(Cicinelli et al., 2014).
4/20/2017ABOUBAKR ELNASHAR
3. In RIF:
CE was identified in 30.3% to 66%
Women diagnosed with CE had lower IR
(11.5%) after IVF
(Quaas and Dokras, 2008).
4/20/2017ABOUBAKR ELNASHAR
Mechanism
Altered endometrial receptivity by
1. Abnormal infiltration of plasma cells
2. Secretion of IgM, IgG, and IgA antibodies
(Kasius et al, 2011).
3. Alteration in:
 Endometrial cytokine production
[Maybin et al, 2011],
 Secretion of paracrine factors
[Matteo et al, 2009, Di Pietro et al, 2013].
 Endometrial expression of genes
(Johnston-MacAnanny, 2010).
4. Delay differentiation of the EM in the mid-
secretory phase (out-of-phase morphology)
[Mishra et al, 2008].
4/20/2017ABOUBAKR ELNASHAR
3. PREVALENCE
Highly variable
RM: 42.9% to 56%.
RIF: 30.3% to 66%
(Johnston-MacAnanny et al, 2010; Cicinelli et al, 2015)
1. Small sizes of some studies
2. Difference in:
1. Ethnicities
2. Definitions of RM and RIF
3. Techniques used for diagnosis.
4. Histologic definition of CE
4/20/2017ABOUBAKR ELNASHAR
4. CAUSES
Infectious agents:
(Cicinelli et al, 2014).
Gonorrhea
Chlamydia
mycoplasma,
ureaplasma,
Escherichia coli,
Streptococcus spp.,
Staphylococcus spp.,
Enterococcus faecalis,
Yeast, and
Tuberculosis (Romero et al, 2004).
CE can result from retained tissue:
incomplete pregnancy loss or
retained placental tissue
(Haggerty et al, 2005).
4/20/2017ABOUBAKR ELNASHAR
5. CLINICAL PICTURE
Usually asymptomatic
Can present with
Chronic pelvic pain
Dyspareunia
Abnormal uterine bleeding
Persistent vaginal discharge
(Romero et al, 2004).
4/20/2017ABOUBAKR ELNASHAR
6. DIAGNOSIS
Different methods
Histology
H&E
IHC
Hysteroscopy
Culture
4/20/2017ABOUBAKR ELNASHAR
1. Histologic diagnosis using H&E
Gold standard for the diagnosis
(Kasius et al.,2011)
Time-consuming and difficult.
Low diagnostic rate (<10%)
[Kasius et al, 2011, McQueen et al, 2014]
±miss the diagnosis.
{normal presence of leukocytes in the
endometrium especially before
menstruation}
[Kasius et al, 2012].
± over diagnosis
{Plasma cells can appear morphologically
similar to other stromal cells and leukocytes}
(Greenwood, Moran, 1981).
4/20/2017ABOUBAKR ELNASHAR
For diagnosis:
one plasma cell in the endometrial stroma
(Johnston-MacAnanny et al 2011, Kasius et al, 2011; McQueen et al, 2014).
At least 5 plasma cells
(Bayer-Garner et al, 2004).
4/20/2017ABOUBAKR ELNASHAR
Chronic endometritis on endometrial biopsy.
Plasma cells identified by morphology using H&E
staining.
4/20/2017ABOUBAKR ELNASHAR
2. Immunohistochemistry (IHC)
with CD138 (syndecan-1)
Chronic endometritis on endometrial biopsy.
Plasma cells identified in brown by immunohistochemical CD138 staining.
4/20/2017ABOUBAKR ELNASHAR
Higher sensitivity
56%, as compared to a 13%for H&E staining
[McQueen et al, 2015].
(Miguel et al, 2011)
More accurate:
(Bayer-Garner et al, 2001).
Reducing false-negative diagnosis
(McQueen et al.2014)
Not yet recommended in daily clinical practice
Not widely used for the diagnosis of CE
IHCH&E
100%75%Sensitivity
100%65%Specificity
4/20/2017ABOUBAKR ELNASHAR
3. Office Hysteroscopy
In the follicular phase (between D6 and 12) of the
menstrual cycle.
Diagnosis:
1. Mucosal edema,
2. Focal or diffuse endometrial hyperemia,
3. Micropolyps (<1 mm)
(Cicinelli et al, 2005).
4/20/2017ABOUBAKR ELNASHAR
Micropolyps
 identified in 50%-54% of patients with a
histologically confirmed CE
(Cicinelli et al, 2005; Bouet et al, 2016)
{inflammatory microenvironment}.
Biopsy:
1. Higher density of B cells and plasma cells
2. Lower density of natural killer cells
(Kitaya et al, 2012).
 This explains decreased endometrial receptivity in
CE: RM and RIF
4/20/2017ABOUBAKR ELNASHAR
Chronic endometritis: ‘‘strawberry aspect.’’
Large area of hyperemic endometrium flushed with
white central points 4/20/2017ABOUBAKR ELNASHAR
Sensitivity:
40%
(Bouet et al, 2016).
much greater sens
Specificity
80%
(Bakas et al, 2014; Bouet et al, 2016)
dependent on the clinician's experience
Accuracy
93.4%
[Cicinelli et al, 2008,2010].
Normal hysteroscopy
relatively accurate predictor of successful pregnancy
after ART
[Cicinelli et al , 2015].
4/20/2017ABOUBAKR ELNASHAR
4. Culture:
Positive in 75% of histologically confirmed CE
Common bacteria:
Escherichia coli, Enterococcus faecalis
Streptococcus agalactiae: 77.5%
Mycoplasmae/Ureaplasma: 25%
Chlamydia: 13%
(Cicinelli et al, 2014).
Often a causal organism cannot be identified.
CE have no correlation with
Bacterial colonization of the EM or
Clinical presentation of PID
[Korrn et al, 1995; Andrews et al, 2005].
4/20/2017ABOUBAKR ELNASHAR
The recent view that
Uterine cavity is normally not sterile
Presence of micro-organisms does not mean
inflammation
(Cowling et al., 1992; Eckert et al.,2003).
It is not just the presence of infectious agent within
the internal genital tract
The most critical issue that determines the pathology
 interactions between:
infectious agents and
endometrial environment
(Eckert et al.,2003)
4/20/2017ABOUBAKR ELNASHAR
7. TREATMENT
Regimen:
Ofloxacin: 400 mg daily for 2w OR
Doxycycline: 100 mg twice daily for 2 w
Histological cure:
70-95%
Persistent CE:
Ciprofloxacin: 500mg and
Metronidazole: 500 mg twice daily for 2 w
4/20/2017ABOUBAKR ELNASHAR
LBR in RM with CE
After ttBefore tt
56%7%McQueen et al. 2014
LBR in RIF with CE
After ttBefore tt
60.8%13.3%Cicinelli et al, 2015
Results of treatment
4/20/2017ABOUBAKR ELNASHAR
CONCLUSIONS
1. Definition:
Persistent inflammation of the endometrium
characterized by the presence of plasma cells
2. Clinical implication
Correlation between CE and RM or RIF
3. Prevalence
Highly variable
RM: 42.9% to 56%.
RIF: 30.3% to 66%
4. Clinical picture
Usually asymptomatic
4/20/2017ABOUBAKR ELNASHAR
5. Diagnosis:
1. Conventional H&E
2. IHC
3. Office hysteroscopy
4. Culture
6. Treatment:
Ofloxacin or Doxycycline for 2w
4/20/2017ABOUBAKR ELNASHAR
You can get this lecture from:
1.My scientific page on Face book:
Aboubakr Elnashar Lectures.
https://www.facebook.com/groups/2277
44884091351/
2.Slide share web site
3. elnashar53@hotmail.com
4.My clinic: Althwara st, Mansura, Egypt
4/20/2017ABOUBAKR ELNASHAR

More Related Content

PPTX
Oral treatment for endometriosis
PPTX
Optimizing iui results
PPTX
Hysteroscopy and infertility
PPTX
Endometriosis and Infertility
PPTX
Endometriosis in IVF
PPTX
Laparoscopic management of endometriosis
PDF
Recurrent implantation failure
PPT
Optimal endometrial preparation for frozen embryo transfer cycles
Oral treatment for endometriosis
Optimizing iui results
Hysteroscopy and infertility
Endometriosis and Infertility
Endometriosis in IVF
Laparoscopic management of endometriosis
Recurrent implantation failure
Optimal endometrial preparation for frozen embryo transfer cycles

What's hot (20)

PDF
Recurrent implantation failure: British fertility society Guidelines2020
PDF
ADENOMYOSIS AND INFERTILITY: UPDATE
PPTX
Management of Infertility in Endometriosis
PPTX
Laparoscopy and fertility
PDF
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
PPTX
Reproductive organ transplantation
PPT
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
PPTX
Thin Endometrium
PDF
Endometriosis and Infertility
PDF
Thin Endometrium
PDF
Endometriosis: ESHRE2014& NICE2017 Guidelines
PPSX
ADOLESCENT ENDOMETRIOSIS
PDF
CAESAREAN SCAR DEFECT
PDF
Ovarian stimulation
PPTX
Chronic endometritis and its effect on Fertility
PPT
Endometriosis and art
PPTX
Diagnosis and classification of tubal factor infertility
PPTX
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
PPTX
Basics of tvs color doppler
PDF
ART PREGNANCY COMPLICATIONS
Recurrent implantation failure: British fertility society Guidelines2020
ADENOMYOSIS AND INFERTILITY: UPDATE
Management of Infertility in Endometriosis
Laparoscopy and fertility
FIGO guidelines on Placenta Accreta Spectrum Disorders: Conservative manage...
Reproductive organ transplantation
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
Thin Endometrium
Endometriosis and Infertility
Thin Endometrium
Endometriosis: ESHRE2014& NICE2017 Guidelines
ADOLESCENT ENDOMETRIOSIS
CAESAREAN SCAR DEFECT
Ovarian stimulation
Chronic endometritis and its effect on Fertility
Endometriosis and art
Diagnosis and classification of tubal factor infertility
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Basics of tvs color doppler
ART PREGNANCY COMPLICATIONS
Ad

Similar to Chronic Endometritis in Repeated miscarriage and Repeated implantation failure (20)

PPSX
Adjuncts in IVF laboratory: Current evidence
PPTX
Nuhu et al_Poster NAPA2016 correction and observation
PDF
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
PDF
Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
PDF
Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote ...
PPTX
Updates in endometrial receptivity
PPTX
Aisha Ishaq Breast Cancer Diagnosis_043536.pptx
PDF
Current evidence for management of Refractory Endometrium
PDF
Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli...
PPT
Follow up Children after Sperm Injection
PPT
PDF
Management of Endometrioma associated infertility
PDF
3 prof james bently hpv vaccination 2014
PDF
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
PDF
Snp microarray based 24 chromosome
PPTX
Future Perspectives in the ART Lab
PPTX
Molecular subtypes of breast cancer
PDF
The prevalence of extended spectrum beta-lactamases (ESBLs) among Escherichia...
PPT
Cervical Cancer Vaccine - Do we need it in India
PDF
Hysteroscopy Overview of systematic reviews
Adjuncts in IVF laboratory: Current evidence
Nuhu et al_Poster NAPA2016 correction and observation
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote ...
Updates in endometrial receptivity
Aisha Ishaq Breast Cancer Diagnosis_043536.pptx
Current evidence for management of Refractory Endometrium
Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli...
Follow up Children after Sperm Injection
Management of Endometrioma associated infertility
3 prof james bently hpv vaccination 2014
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Snp microarray based 24 chromosome
Future Perspectives in the ART Lab
Molecular subtypes of breast cancer
The prevalence of extended spectrum beta-lactamases (ESBLs) among Escherichia...
Cervical Cancer Vaccine - Do we need it in India
Hysteroscopy Overview of systematic reviews
Ad

More from Aboubakr Elnashar (20)

PDF
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
PDF
hepatitis B.pdf
PDF
hepatitis c2022.pdf
PDF
Adenomyosis associated infertility
PDF
Endometriosis associated infertility: ESHRE2022
PDF
Adenxal mass guidelines2020
PDF
Aesthetic gynecology controversy
PDF
Hormonal assay in clinical gyn
PDF
FIRST TRIMESTER ANC OF IVF
PDF
Unnecessary investigations in reproductive medicine
PDF
Infertility prevention
PDF
Individualisation of controlled ovarian stimulation
PDF
Female infertility
PDF
Maternal near miss
PDF
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
PDF
cesarean birth: procedural aspects: NICE2021
PDF
Management of pregnancy of unknown location
PDF
Aerobic Vaginitis
PDF
COVID 19 infection and pregnancy RCOG2021
PDF
Imaging in pregnancy 2 in1
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
hepatitis B.pdf
hepatitis c2022.pdf
Adenomyosis associated infertility
Endometriosis associated infertility: ESHRE2022
Adenxal mass guidelines2020
Aesthetic gynecology controversy
Hormonal assay in clinical gyn
FIRST TRIMESTER ANC OF IVF
Unnecessary investigations in reproductive medicine
Infertility prevention
Individualisation of controlled ovarian stimulation
Female infertility
Maternal near miss
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
cesarean birth: procedural aspects: NICE2021
Management of pregnancy of unknown location
Aerobic Vaginitis
COVID 19 infection and pregnancy RCOG2021
Imaging in pregnancy 2 in1

Recently uploaded (20)

PPTX
Antepartum_Haemorrhage_Guidelines_2024.pptx
PPTX
SHOCK- lectures on types of shock ,and complications w
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PPTX
Wheat allergies and Disease in gastroenterology
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
Physiology of Thyroid Hormones.pptx
PPT
Infections Member of Royal College of Physicians.ppt
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPT
Dermatology for member of royalcollege.ppt
PPTX
preoerative assessment in anesthesia and critical care medicine
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
Antepartum_Haemorrhage_Guidelines_2024.pptx
SHOCK- lectures on types of shock ,and complications w
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Wheat allergies and Disease in gastroenterology
PEADIATRICS NOTES.docx lecture notes for medical students
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
AGE(Acute Gastroenteritis)pdf. Specific.
Physiology of Thyroid Hormones.pptx
Infections Member of Royal College of Physicians.ppt
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Dermatology for member of royalcollege.ppt
preoerative assessment in anesthesia and critical care medicine
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
The_EHRA_Book_of_Interventional Electrophysiology.pdf
Vaccines and immunization including cold chain , Open vial policy.pptx
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study

Chronic Endometritis in Repeated miscarriage and Repeated implantation failure

  • 1. Chronic Endometritis in Repeated miscarriage and Repeated implantation failure Prof. Aboubakr Elnashar Benha university, Egypt4/20/2017ABOUBAKR ELNASHAR
  • 3. 1. DEFINITION CE: Chronic inflammation of the endometrial lining (Romero et al, 2004). Persistent inflammation of the endometrium that is characterized by the presence of plasma cells (Johnston-MacAnanny, 2010). 4/20/2017ABOUBAKR ELNASHAR
  • 4. RM: 3 or more consecutive failed pregnancies (RCOG, 2011) 2 or more (ASRM, 2008)  Causes: uterine abnormalities Antiphospholipid antibody syndrome endocrine disorders. parental chromosomal imbalances/translocations 50% unexplained (Stephenson,1996). 4/20/2017ABOUBAKR ELNASHAR
  • 5. RIF Failure to conceive following 2 or 3 ET cycles, or Cumulative transfer of 10 good quality embryos (El-Toukhy and Taranissi, 2006). Causes: Embryonic Maternal: uterine anatomic abnormalities thrombophilia, non-receptive endometrium immunological (Salim et al., 2002). Idiopathic 4/20/2017ABOUBAKR ELNASHAR
  • 6. Recently, there has been increasing interest in the role of CE in RM and RIF Limited publications The impact of CE on reproductive capacity: controversial 4/20/2017ABOUBAKR ELNASHAR
  • 7. 2. CLINICAL IMPLICATION 1. Infertility:  CE: RM: 42.9% to 56%. RIF: 30.3% to 66% Infertile women: 2.8-9% (Kasius et al, 2011, Viana et al, 2015) suggesting: Correlation between CE and RM or RIF rather than infertility {create a suboptimal IU environment hamper endometrial receptivity} ±cause infertility {endometrium is characterized by an abnormal pattern of lymphocyte: an aberrant endometrial microenvironment } (Matteo et al., 2009). 4/20/2017ABOUBAKR ELNASHAR
  • 8. 2. In RM: CE is a frequent finding (42.9% to 56%). Antibiotic tt: significantly higher rate of successful pregnancies compared with women who were not treated or with persistent disease (Cicinelli et al., 2014). 4/20/2017ABOUBAKR ELNASHAR
  • 9. 3. In RIF: CE was identified in 30.3% to 66% Women diagnosed with CE had lower IR (11.5%) after IVF (Quaas and Dokras, 2008). 4/20/2017ABOUBAKR ELNASHAR
  • 10. Mechanism Altered endometrial receptivity by 1. Abnormal infiltration of plasma cells 2. Secretion of IgM, IgG, and IgA antibodies (Kasius et al, 2011). 3. Alteration in:  Endometrial cytokine production [Maybin et al, 2011],  Secretion of paracrine factors [Matteo et al, 2009, Di Pietro et al, 2013].  Endometrial expression of genes (Johnston-MacAnanny, 2010). 4. Delay differentiation of the EM in the mid- secretory phase (out-of-phase morphology) [Mishra et al, 2008]. 4/20/2017ABOUBAKR ELNASHAR
  • 11. 3. PREVALENCE Highly variable RM: 42.9% to 56%. RIF: 30.3% to 66% (Johnston-MacAnanny et al, 2010; Cicinelli et al, 2015) 1. Small sizes of some studies 2. Difference in: 1. Ethnicities 2. Definitions of RM and RIF 3. Techniques used for diagnosis. 4. Histologic definition of CE 4/20/2017ABOUBAKR ELNASHAR
  • 12. 4. CAUSES Infectious agents: (Cicinelli et al, 2014). Gonorrhea Chlamydia mycoplasma, ureaplasma, Escherichia coli, Streptococcus spp., Staphylococcus spp., Enterococcus faecalis, Yeast, and Tuberculosis (Romero et al, 2004). CE can result from retained tissue: incomplete pregnancy loss or retained placental tissue (Haggerty et al, 2005). 4/20/2017ABOUBAKR ELNASHAR
  • 13. 5. CLINICAL PICTURE Usually asymptomatic Can present with Chronic pelvic pain Dyspareunia Abnormal uterine bleeding Persistent vaginal discharge (Romero et al, 2004). 4/20/2017ABOUBAKR ELNASHAR
  • 15. 1. Histologic diagnosis using H&E Gold standard for the diagnosis (Kasius et al.,2011) Time-consuming and difficult. Low diagnostic rate (<10%) [Kasius et al, 2011, McQueen et al, 2014] ±miss the diagnosis. {normal presence of leukocytes in the endometrium especially before menstruation} [Kasius et al, 2012]. ± over diagnosis {Plasma cells can appear morphologically similar to other stromal cells and leukocytes} (Greenwood, Moran, 1981). 4/20/2017ABOUBAKR ELNASHAR
  • 16. For diagnosis: one plasma cell in the endometrial stroma (Johnston-MacAnanny et al 2011, Kasius et al, 2011; McQueen et al, 2014). At least 5 plasma cells (Bayer-Garner et al, 2004). 4/20/2017ABOUBAKR ELNASHAR
  • 17. Chronic endometritis on endometrial biopsy. Plasma cells identified by morphology using H&E staining. 4/20/2017ABOUBAKR ELNASHAR
  • 18. 2. Immunohistochemistry (IHC) with CD138 (syndecan-1) Chronic endometritis on endometrial biopsy. Plasma cells identified in brown by immunohistochemical CD138 staining. 4/20/2017ABOUBAKR ELNASHAR
  • 19. Higher sensitivity 56%, as compared to a 13%for H&E staining [McQueen et al, 2015]. (Miguel et al, 2011) More accurate: (Bayer-Garner et al, 2001). Reducing false-negative diagnosis (McQueen et al.2014) Not yet recommended in daily clinical practice Not widely used for the diagnosis of CE IHCH&E 100%75%Sensitivity 100%65%Specificity 4/20/2017ABOUBAKR ELNASHAR
  • 20. 3. Office Hysteroscopy In the follicular phase (between D6 and 12) of the menstrual cycle. Diagnosis: 1. Mucosal edema, 2. Focal or diffuse endometrial hyperemia, 3. Micropolyps (<1 mm) (Cicinelli et al, 2005). 4/20/2017ABOUBAKR ELNASHAR
  • 21. Micropolyps  identified in 50%-54% of patients with a histologically confirmed CE (Cicinelli et al, 2005; Bouet et al, 2016) {inflammatory microenvironment}. Biopsy: 1. Higher density of B cells and plasma cells 2. Lower density of natural killer cells (Kitaya et al, 2012).  This explains decreased endometrial receptivity in CE: RM and RIF 4/20/2017ABOUBAKR ELNASHAR
  • 22. Chronic endometritis: ‘‘strawberry aspect.’’ Large area of hyperemic endometrium flushed with white central points 4/20/2017ABOUBAKR ELNASHAR
  • 23. Sensitivity: 40% (Bouet et al, 2016). much greater sens Specificity 80% (Bakas et al, 2014; Bouet et al, 2016) dependent on the clinician's experience Accuracy 93.4% [Cicinelli et al, 2008,2010]. Normal hysteroscopy relatively accurate predictor of successful pregnancy after ART [Cicinelli et al , 2015]. 4/20/2017ABOUBAKR ELNASHAR
  • 24. 4. Culture: Positive in 75% of histologically confirmed CE Common bacteria: Escherichia coli, Enterococcus faecalis Streptococcus agalactiae: 77.5% Mycoplasmae/Ureaplasma: 25% Chlamydia: 13% (Cicinelli et al, 2014). Often a causal organism cannot be identified. CE have no correlation with Bacterial colonization of the EM or Clinical presentation of PID [Korrn et al, 1995; Andrews et al, 2005]. 4/20/2017ABOUBAKR ELNASHAR
  • 25. The recent view that Uterine cavity is normally not sterile Presence of micro-organisms does not mean inflammation (Cowling et al., 1992; Eckert et al.,2003). It is not just the presence of infectious agent within the internal genital tract The most critical issue that determines the pathology  interactions between: infectious agents and endometrial environment (Eckert et al.,2003) 4/20/2017ABOUBAKR ELNASHAR
  • 26. 7. TREATMENT Regimen: Ofloxacin: 400 mg daily for 2w OR Doxycycline: 100 mg twice daily for 2 w Histological cure: 70-95% Persistent CE: Ciprofloxacin: 500mg and Metronidazole: 500 mg twice daily for 2 w 4/20/2017ABOUBAKR ELNASHAR
  • 27. LBR in RM with CE After ttBefore tt 56%7%McQueen et al. 2014 LBR in RIF with CE After ttBefore tt 60.8%13.3%Cicinelli et al, 2015 Results of treatment 4/20/2017ABOUBAKR ELNASHAR
  • 28. CONCLUSIONS 1. Definition: Persistent inflammation of the endometrium characterized by the presence of plasma cells 2. Clinical implication Correlation between CE and RM or RIF 3. Prevalence Highly variable RM: 42.9% to 56%. RIF: 30.3% to 66% 4. Clinical picture Usually asymptomatic 4/20/2017ABOUBAKR ELNASHAR
  • 29. 5. Diagnosis: 1. Conventional H&E 2. IHC 3. Office hysteroscopy 4. Culture 6. Treatment: Ofloxacin or Doxycycline for 2w 4/20/2017ABOUBAKR ELNASHAR
  • 30. You can get this lecture from: 1.My scientific page on Face book: Aboubakr Elnashar Lectures. https://www.facebook.com/groups/2277 44884091351/ 2.Slide share web site 3. elnashar53@hotmail.com 4.My clinic: Althwara st, Mansura, Egypt 4/20/2017ABOUBAKR ELNASHAR